-
1 Comment
Ra Medical Systems, Inc is currently in a long term downtrend where the price is trading 27.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Ra Medical Systems, Inc's total revenue sank by 12.4% to $1M since the same quarter in the previous year.
Its net income has dropped by 7.2% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 2.1% to $-9M since the same quarter in the previous year.
Based on the above factors, Ra Medical Systems, Inc gets an overall score of 2/5.
Sector | Healthcare |
---|---|
Industry | Medical Devices |
Exchange | NYSE MKT |
CurrencyCode | USD |
ISIN | US74933X2036 |
Beta | 0.18 |
---|---|
Market Cap | 4M |
PE Ratio | None |
Target Price | 7 |
Dividend Yield | 0.0% |
Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RMED using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025